6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
25m ago	UFP Industries Expands Pallet Manufacturing Network Through Acquisition
25m ago	PodcastOne (Nasdaq: PODC) Anticipates Record FY 2026 Results of $61M+ Revenue and $6.3M+ Adjusted EBITDA*, Up +1,476% YOY
50m ago	Linkhome Holdings Inc. Signs MOU to Acquire Mortgage One Group, Accelerating Nationwide Expansion of AI Real Estate & Fintech Platform
51m ago	Deluxe and MRI Software Partner to Enhance Payment Capabilities for Property Management Companies
52m ago	Box Launches Box Automate to Orchestrate Agentic Workflows

About

Dr. Reddy's Laboratories Limited (NSE:DRREDDY) — investor relations, events, news, and company updates on 6ix.

Latest News

Press Release Mar 21 2026

Dr. Reddy’s Announces USFDA Acceptance to Review Its Biologics License Application (BLA) for Proposed Interchangeable Biosimilar, Abatacept

Press Release Feb 18 2026

Press Release Jan 14 2026

Dr. Reddy’s Announces the First-to-Market Launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the Generic Equivalent of Extra-Strength Pataday® Once Daily Relief, in the U.S.

Financials

Revenue

₹345.83 B

Market Cap

₹1.01 T

P/E Ratio

17.87

EPS

67.93

Dividend Yield

0.66%

Community Chat

Ask AI